학술논문

A transcriptome-wide association study of high-grade serous epithelial ovarian cancer identifies new susceptibility genes and splice variants
Document Type
article
Source
Nature Genetics. 51(5)
Subject
Biological Sciences
Genetics
Clinical Research
Prevention
Biotechnology
Human Genome
Ovarian Cancer
Rare Diseases
Cancer
2.1 Biological and endogenous factors
Aetiology
Alternative Splicing
Carcinoma
Ovarian Epithelial
Cell Cycle Proteins
Cell Line
Tumor
Databases
Genetic
Endosomal Sorting Complexes Required for Transport
Female
Gene Expression Regulation
Neoplastic
Gene Knockout Techniques
Genetic Predisposition to Disease
Genome-Wide Association Study
Humans
Models
Genetic
Nuclear Proteins
Ovarian Neoplasms
Polymorphism
Single Nucleotide
Transcriptome
Ovarian Cancer Association Consortium
Medical and Health Sciences
Developmental Biology
Agricultural biotechnology
Bioinformatics and computational biology
Language
Abstract
We sought to identify susceptibility genes for high-grade serous ovarian cancer (HGSOC) by performing a transcriptome-wide association study of gene expression and splice junction usage in HGSOC-relevant tissue types (N = 2,169) and the largest genome-wide association study available for HGSOC (N = 13,037 cases and 40,941 controls). We identified 25 transcriptome-wide association study significant genes, 7 at the junction level only, including LRRC46 at 19q21.32, (P = 1 × 10-9), CHMP4C at 8q21 (P = 2 × 10-11) and a PRC1 junction at 15q26 (P = 7 × 10-9). In vitro assays for CHMP4C showed that the associated variant induces allele-specific exon inclusion (P = 0.0024). Functional screens in HGSOC cell lines found evidence of essentiality for three of the new genes we identified: HAUS6, KANSL1 and PRC1, with the latter comparable to MYC. Our study implicates at least one target gene for 6 out of 13 distinct genome-wide association study regions, identifying 23 new candidate susceptibility genes for HGSOC.